{"product_id":"klow-blend-ghk-cu-bpc-157-tb-500-kpv-80mg-biolongevity-labs","title":"KLOW Blend (GHK-Cu, BPC-157, TB-500, KPV) X 80mg","description":"\u003cp\u003eDescription-- \u003c!--StartFragment --\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003cstrong\u003eLaboratory Research Overview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaboratory investigations highlight synergistic mechanisms across cellular repair, vascular formation, and inflammatory modulation—providing valuable tools for in vitro research applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAngiogenesis and Vascular Formation\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Upregulates VEGFR2 expression without altering VEGF-A levels, activating the VEGFR2–Akt–eNOS signaling cascade in endothelial cell cultures [1].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e At nanomolar concentrations, increased VEGF and bFGF expression by 230% in irradiated fibroblasts [2]; liposomal delivery enhanced HUVEC proliferation by 33.1% with elevated cell cycle protein expression [3].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Acts as a potent endothelial chemoattractant, stimulating 4–6-fold increases in HUVEC migration; activity observed at ~50 nM concentration via LKKTET sequence [4].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTissue Repair and Regeneration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Modulates ~31% of human genes (4,192 genes) with ≥50% expression changes, activating integrin-linked kinase pathways [5].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Promotes regeneration via FAK–paxillin pathway activation, increasing phosphorylation of focal adhesion proteins [6].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Sequesters G-actin in a 1:1 ratio; rat wound models showed 42–61% increased reepithelialization with enhanced collagen deposition [7].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCollagen Synthesis and Extracellular Matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Stimulates collagen synthesis at picomolar–nanomolar concentrations; increased decorin by 302% and glycosaminoglycan accumulation [8].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Enhances collagen, reticulin, and vascular formation in animal models [9].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Promotes organized collagen deposition with anti-fibrotic properties, reducing myofibroblast formation [10].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInflammatory Modulation\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Inhibits NF-κB p65 and p38 MAPK pathways, reducing ROS and cytokines TNF-α and IL-6 [2].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Decreases TNF-α, IL-6, IL-1β, COX-2 expression, and myeloperoxidase activity [11].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Biphasic regulation—downregulates TNF-α (6.2-fold) and IL-6 (4.1-fold), while upregulating IL-10 (8.1-fold) [12].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV:\u003c\/strong\u003e Inhibits NF-κB activation via IκB-α stabilization; reduces cytokine secretion in epithelial and macrophage cultures [13,14].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNeuroprotection and Neural Mechanisms\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Increases NGF and neurotrophins NT-3\/NT-4; improved spatial memory in aging models [15].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Modulates dopaminergic systems without direct receptor binding [16].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Provides neuroprotection via caspase-3 inhibition; promotes oligodendrocyte progenitor proliferation through p38 MAPK upregulation [17].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCellular Migration and Proliferation\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e G-actin sequestration drives migration; photorelease studies show directional cell turning [7].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Chemoattractant for macrophages, mast cells, and endothelial cells [18].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Regulates migration via ERK1\/2 phosphorylation; transcription factors c-Fos (4.99-fold), c-Jun (7.05-fold), Egr-1 (3.70-fold) upregulated [19].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV:\u003c\/strong\u003e Promotes keratinocyte and fibroblast migration; increased viability in corneal epithelial cultures [20].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWound Healing Mechanisms\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Accelerates repair phases including inflammation, collagen deposition, angiogenesis, and epithelial recovery [9].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Enhances systemic and local remodeling; collagen dressings improved contraction and antioxidant levels [5].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Promotes organized repair with anti-scarring effects; increased wound contraction (11%) and reepithelialization (42–61%) [10].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV:\u003c\/strong\u003e Accelerates mucosal and corneal healing; complete reepithelialization within 60 hours [14,20].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOxidative Stress Response\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e Reduces ROS, increases superoxide dismutase activity, quenches radicals [21].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e Upregulates antioxidant enzymes Cu\/Zn-SOD and catalase [11].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e Scavenges free radicals, normalizes NO and MDA levels, increases HO-1 and NOS-3 expression [11].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV:\u003c\/strong\u003e Inhibits ROS in keratinocytes via ERK and p38 MAPK modulation [22].\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDisclaimer:\u003c\/strong\u003e \u003cstrong\u003eThese peptides are intended strictly for in vitro research applications. They are not for human consumption or therapeutic use\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003c!--EndFragment --\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e\n\u003cstrong\u003e[\u003c\/strong\u003e1] M.-J. Hsieh \u003cem\u003eet al.\u003c\/em\u003e, “Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation,” Springer Science and Business Media LLC, Nov. 2016. doi: 10.1007\/s00109-016-1488-y. Available: \u003ca href=\"https:\/\/doi.org\/10.1007\/s00109-016-1488-y\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1007\/s00109-016-1488-y\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[2] Y. Dou, A. Lee, L. Zhu, J. Morton, and W. Ladiges, “The potential of GHK as an anti-aging peptide,” Ant Publishing, Mar. 2020. doi: 10.31491\/apt.2020.03.014. Available: \u003ca href=\"https:\/\/doi.org\/10.31491\/apt.2020.03.014\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.31491\/apt.2020.03.014\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[3] X. Wang \u003cem\u003eet al.\u003c\/em\u003e, “GHK‐Cu‐liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis,” Wiley, Apr. 2017. doi: 10.1111\/wrr.12520. Available: \u003ca href=\"https:\/\/doi.org\/10.1111\/wrr.12520\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1111\/wrr.12520\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[4] K. M. Malinda, A. L. Goldstein, and H. K. Kueinman, “Thymosin β            4            stimulates directional migration of human umbilical vein endothelial cells,” Wiley, May 1997. doi: 10.1096\/fasebj.11.6.9194528. Available: \u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[5] L. Pickart and A. Margolina, “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data,” MDPI AG, Jul. 2018. doi: 10.3390\/ijms19071987. Available: \u003ca href=\"https:\/\/doi.org\/10.3390\/ijms19071987\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3390\/ijms19071987\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[6] C.-H. Chang, W.-C. Tsai, M.-S. Lin, Y.-H. Hsu, and J.-H. S. Pang, “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration,” American Physiological Society, Mar. 2011. doi: 10.1152\/japplphysiol.00945.2010. Available: \u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[7] B. Xue, C. Leyrat, J. M. Grimes, and R. C. Robinson, “Structural basis of thymosin-β4\/profilin exchange leading to actin filament polymerization,” Proceedings of the National Academy of Sciences, Oct. 2014. doi: 10.1073\/pnas.1412271111. Available: \u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.1412271111\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1073\/pnas.1412271111\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[8] F.-X. Maquart, L. Pickart, M. Laurent, P. Gillery, J.-C. Monboisse, and J.-P. Borel, “Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+,” Wiley, Oct. 1988. doi: 10.1016\/0014-5793(88)80509-x. Available: \u003ca href=\"https:\/\/doi.org\/10.1016\/0014-5793(88)80509-x\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1016\/0014-5793(88)80509-x\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[9] S. Seiwerth \u003cem\u003eet al.\u003c\/em\u003e, “Stable Gastric Pentadecapeptide BPC 157 and Wound Healing,” Frontiers Media SA, Jun. 2021. doi: 10.3389\/fphar.2021.627533. Available: \u003ca href=\"https:\/\/doi.org\/10.3389\/fphar.2021.627533\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3389\/fphar.2021.627533\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[10] K. M. Malinda \u003cem\u003eet al.\u003c\/em\u003e, “Thymosin beta4 accelerates wound healing.,” \u003cem\u003eJournal of Investigative Dermatology\u003c\/em\u003e, vol. 113 3, pp. 364–8, 1999.\u003c\/h5\u003e\n\u003ch5\u003e[11] H. Demirtaş, A. Özer, A. K. Yıldırım, A. D. Dursun, Ş. C. Sezen, and M. Arslan, “Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury,” MDPI AG, Feb. 2025. doi: 10.3390\/medicina61020291. Available: \u003ca href=\"https:\/\/doi.org\/10.3390\/medicina61020291\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3390\/medicina61020291\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[12] M. A. Evans \u003cem\u003eet al.\u003c\/em\u003e, “Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing,” Springer Science and Business Media LLC, Jul. 2013. doi: 10.1038\/ncomms3081. Available: \u003ca href=\"https:\/\/doi.org\/10.1038\/ncomms3081\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1038\/ncomms3081\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[13] G. Dalmasso, L. Charrier–Hisamuddin, H. T. Thu Nguyen, Y. Yan, S. Sitaraman, and D. Merlin, “PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation,” Elsevier BV, Jan. 2008. doi: 10.1053\/j.gastro.2007.10.026. Available: \u003ca href=\"https:\/\/doi.org\/10.1053\/j.gastro.2007.10.026\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1053\/j.gastro.2007.10.026\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[14] B. Xiao \u003cem\u003eet al.\u003c\/em\u003e, “Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis,” Elsevier BV, Jul. 2017. doi: 10.1016\/j.ymthe.2016.11.020. Available: \u003ca href=\"https:\/\/doi.org\/10.1016\/j.ymthe.2016.11.020\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1016\/j.ymthe.2016.11.020\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[15] L. Pickart, J. M. Vasquez-Soltero, and A. Margolina, “The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health,” Hindawi Limited, 2012. doi: 10.1155\/2012\/324832. Available: \u003ca href=\"https:\/\/doi.org\/10.1155\/2012\/324832\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1155\/2012\/324832\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[16] J. Vukojevic \u003cem\u003eet al.\u003c\/em\u003e, “Pentadecapeptide BPC 157 and the central nervous system,” Medknow, 2022. doi: 10.4103\/1673-5374.320969. Available: \u003ca href=\"https:\/\/doi.org\/10.4103\/1673-5374.320969\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.4103\/1673-5374.320969\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[17] S. Kim, J. Choi, and J. Kwon, “Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106–126) via Neurotrophic Factor Signaling,” MDPI AG, May 2023. doi: 10.3390\/molecules28093920. Available: \u003ca href=\"https:\/\/doi.org\/10.3390\/molecules28093920\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3390\/molecules28093920\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[18] L. Pickart, J. M. Vasquez-Soltero, and A. Margolina, “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration,” Wiley, 2015. doi: 10.1155\/2015\/648108. Available: \u003ca href=\"https:\/\/doi.org\/10.1155\/2015\/648108\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1155\/2015\/648108\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[19] T. Huang \u003cem\u003eet al.\u003c\/em\u003e, “Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro,” Informa UK Limited, Apr. 2015. doi: 10.2147\/dddt.s82030. Available: \u003ca href=\"https:\/\/doi.org\/10.2147\/dddt.s82030\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.2147\/dddt.s82030\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[20] M. Böhm and T. Luger, “Are melanocortin peptides future therapeutics for cutaneous wound healing?,” Wiley, Feb. 2019. doi: 10.1111\/exd.13887. Available: \u003ca href=\"https:\/\/doi.org\/10.1111\/exd.13887\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1111\/exd.13887\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[21] S. Sharma, M. F. Anwar, A. Dinda, M. Singhal, and A. Malik, “In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer,” American Chemical Society (ACS), Nov. 2019. doi: 10.1021\/acsomega.9b00655. Available: \u003ca href=\"https:\/\/doi.org\/10.1021\/acsomega.9b00655\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1021\/acsomega.9b00655\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003ch5\u003e[22] J. Sung, S.-Y. Ju, S. Park, W.-K. Jung, J.-Y. Je, and S.-J. Lee, “Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK\/NF-κB pathway,” Elsevier BV, Aug. 2025. doi: 10.1016\/j.tice.2025.102837. Available: \u003ca href=\"https:\/\/doi.org\/10.1016\/j.tice.2025.102837\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1016\/j.tice.2025.102837\u003c\/a\u003e\n\u003c\/h5\u003e\n\u003cp\u003eLabel--\u003c\/p\u003e\n\u003cstyle type=\"text\/css\"\u003e\n        td {border: 1px solid #cccccc;}\n        br {mso-data-placement: same-cell;}\n        .bold {font-weight: bold;}\n    \u003c\/style\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003cstrong\u003eProperty\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e Gly-His-Lys.Cu.xHAc\u003c\/td\u003e\n\u003ctd\u003eGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\u003c\/td\u003e\n\u003ctd\u003eAc-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/td\u003e\n\u003ctd\u003e Lys-Pro-Val\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eC₁₄H₂₃CuN₆O₄\u003c\/td\u003e\n\u003ctd\u003eC₆₂H₉₈N₁₆O₂₂\u003c\/td\u003e\n\u003ctd\u003eC₂₁₂H₃₅₀N₅₆O₇₈S\u003c\/td\u003e\n\u003ctd\u003eC₁₇H₃₂N₆O₄\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e401.91 g\/mol\u003c\/td\u003e\n\u003ctd\u003e1419.5 g\/mol\u003c\/td\u003e\n\u003ctd\u003e4963.55 g\/mol\u003c\/td\u003e\n\u003ctd\u003e384.48 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePubChem CID\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e73587\u003c\/td\u003e\n\u003ctd\u003e9941957\u003c\/td\u003e\n\u003ctd\u003e16132341\u003c\/td\u003e\n\u003ctd\u003e125672\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCAS Number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e89030-95-5\u003c\/td\u003e\n\u003ctd\u003e137525-51-0\u003c\/td\u003e\n\u003ctd\u003e77591-33-4\u003c\/td\u003e\n\u003ctd\u003e67727-97-3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCopper peptide GHK, Cu-GHK, NSC 661251\u003c\/td\u003e\n\u003ctd\u003ePL-14736, Body-Protection Compound-157, Bepecin\u003c\/td\u003e\n\u003ctd\u003eThymosin-β4 fragment 17-23, TB-500 acetate, Ac-LKKTETQ\u003c\/td\u003e\n\u003ctd\u003eα-MSH fragment (11–13), Tripeptide KPV, Ac-KPV-NH2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eLyophilized Peptides: Our peptides are supplied in a pure, freeze-dried form with no fillers, ensuring long-term stability and integrity during cold storage. Simply reconstitute with sterile solvent before use, and store aliquots at ≤ –20 °C to protect against repeated freeze–thaw cycles.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eDosage-- \u003cstrong\u003eFor Research Purposes Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"elementor-element elementor-element-610a9cdc elementor-widget elementor-widget-text-editor\" data-id=\"610a9cdc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\"\u003e\n\u003cdiv class=\"ql-block\" data-block-id=\"block-32eed5f9-875e-4180-94f9-d97658bf7841\"\u003e\u003cspan\u003eThis content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Biolongevity Labs","offers":[{"title":"Default Title","offer_id":47947452907675,"sku":"BPC-TB5-KPV-GHK-80MG","price":30658.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/BPC-TB5-KPV-GHK-80MG-klow-blend-ghk-cu-bpc-157-tb-500-kpv-80mg-RET.jpg?v=1770933379","url":"https:\/\/fmihealth.com\/products\/klow-blend-ghk-cu-bpc-157-tb-500-kpv-80mg-biolongevity-labs","provider":"FMI health","version":"1.0","type":"link"}